Nierenberg Investment Management Company’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$28.5K	Hold	12,555	–	–	0.02%	35
2025 Q1	$7.98K	Hold	12,555	–	–	﹤0.01%	47
2024 Q4	$12.9K	Hold	12,555	–	–	0.01%	46
2024 Q3	$14.8K	Hold	12,555	–	–	0.01%	46
2024 Q2	$15.3K	Buy	+12,555	New	+$15.3K	0.01%	45